Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RADITOP: Consolidative Radiotherapy in Oligometastatic Biliary Tract Cancer
NCT06502080Phase 2Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jul 2024
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Progression-Free Survival at 2 years. Planned start Jul 2024; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06502080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06502080.